Search 33,000+ CME courses
Back

Catalyst Medical Education, LLC, AKH Inc., Advancing Knowledge in Healthcare

  • Non-alcoholic Fatty Liver Disease

A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration

Addressing disease progression in metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) has long been hindered by the absence of targeted therapies. With the approval and late-stage development of agents featuring novel mechanisms of action, a new era of disease management is here. This activity will showcase clinical integration of thyroid hormone receptor- (THR- ) agonists through interactive, case-based discussions. The most recent advances in noninvasive testing to better detect liver disease along with clinical efficacy and safety data of late-stage therapies will also be discussed.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Nov 1, 2025
  • Last day to claim credit
    Nov 2, 2026 3 weeks left

More from AKH Inc., Advancing Knowledge in Healthcare

See all

This provider’s courses closest to this one

Related courses

See all

Other providers’ courses on the same topic